BioNTech SE (States of America) is listed on the Nasdaq and has a market capitalization of $25.24 billion, with shareholders equity totaling $22.51 billion.
The company employs approximately 1.300 people and operates in the Healthcare sector, within the Biotecnologia industry.
Over the past 12 months, BioNTech SE reported $3.34 billion in revenue, generating net income of $-1.29 billion.
Key financial metrics include a P/E ratio of -19.62, a price-to-book (P/B) ratio of 1.12, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker BNTX.